Both upadacitinib (Rinvoq) and adalimumab (Humira) are proven effective in rheumatoid arthritis (RA) and psoriatic arthritis ...

In an open-label phase 3b trial, the co-administration of Lilly’s IL-17A antagonist Taltz (ixekizumab) and dual GIP/GLP-1 ...

As little as 1 mg/day of finasteride can seriously distort results of prostate-specific antigen (PSA) testing, a study shows. That’s the dosage of Propecia used by more than 4 million men to treat ...

A small dose of finasteride can alter the results of a PSA screening, a study find. As little as 1 mg/day of finasteride can seriously distort the results of a PSA screening for prostate cancer, a ...

Use of statins and non-steroidal anti-inflammatory drugs may interfere with prostate cancer screening. Two of the most common classes of medication — statins and nonsteroidal anti-inflammatory drugs ...